Michael Krause

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry

R. Fleischer, C. Hofer, H. Peters, 2023, BMC Neurology.